title: Rituximab as First Choice for Patients With Refractory Rheumatoid Arthritis: Cost-Effectiveness Analysis in Iran Based on A Systematic Review and Meta-Analysis.
authors.affiliation: Tehran University of Medical Sciences, Tehran, Iran.
authors.forename: S
authors.initials: S
authors.lastname: Ahmadiani
authors.affiliation: Tehran University of Medical Sciences, Tehran, Iran.
authors.forename: S
authors.initials: S
authors.lastname: Nikfar
authors.affiliation: Tehran University of Medical Sciences, Tehran, Iran.
authors.forename: S
authors.initials: S
authors.lastname: Karimi
authors.affiliation: Tehran University of Medical Sciences, Tehran, Iran.
authors.forename: A R
authors.initials: AR
authors.lastname: Jamshidi
authors.affiliation: Tehran University of Medical Sciences, Tehran, Iran.
authors.forename: A
authors.initials: A
authors.lastname: Akbari-Sari
authors.affiliation: Tehran University of Medical Sciences, Tehran, Iran.
authors.forename: A
authors.initials: A
authors.lastname: Kebriaeezadeh